On the mode of action of silver sulfadiazine.
D001224:Aspartic Acid / Q000378:metabolism; D001426:Bacterial Proteins / Q000096:biosynthesis*; D002247:Carbon Isotopes; D002474:Cell-Free System; D002499:Centrifugation, Density Gradient; D004254:DNA Nucleotidyltransferases / Q000378:metabolism; D004261:DNA Replication / Q000187:drug effects; D004269:DNA, Bacterial / Q000032:analysis / Q000096:biosynthesis*; D003851:Deoxyribonucleases; D009691:Nucleic Acid Denaturation; D011485:Protein Binding; D011550:Pseudomonas aeruginosa / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D012329:RNA, Bacterial / Q000096:biosynthesis*; D012270:Ribosomes / Q000187:drug effects; D012834:Silver; D013053:Spectrophotometry; D013237:Stereoisomerism; D013411:Sulfadiazine / Q000494:pharmacology*; D013936:Thymidine / Q000378:metabolism; D014316:Tritium; D014498:Uracil / Q000378:metabolism
D001426:Bacterial Proteins; D002247:Carbon Isotopes; D004269:DNA, Bacterial; D012329:RNA, Bacterial; D013411:Sulfadiazine; D014316:Tritium; D001224:Aspartic Acid; D012834:Silver; D014498:Uracil; D004254:DNA Nucleotidyltransferases; D003851:Deoxyribonucleases; D013936:Thymidine